Join Our 20,000+ Subscribers. Get Weekly News Sent To Your Email
Subscribe to our newsletter and stay updated on the latest Critical Care Medicine related news.
See Past Critical Care Newsletter issues

Subscribe to Newsletter

Metformin Associated with Reduced Mortality in CKD, CHF, and CLD

annals.org January 3, 2017

metformin-associated-with-reduced-mortality-in-ckd-chf-and-cld

Metformin is currently the suggested initial treatment for type 2 diabetes mellitus in the United States. In the past, the U.S. Food and Drug Administration (FDA) did not recommend metformin for patients with chronic kidney disease (CKD), congestive heart failure (CHF), and/or chronic liver disease (CLD) with hepatic impairment.

diabetes FDA kidneys liver study treatment

Impacts of Initial ICU Driving Pressure on Outcomes in Acute Hypoxemic Respiratory Failure

Effects of Surgery on Hemodynamics and Postoperative Delirium in Stanford Type A Aortic Dissection

Implementing a Bedside Percutaneous Tracheostomy and Ultrasound Gastrostomy Team Reduces Length of Stay and Hospital Costs

Predictors of Weaning Failure in Ventilated ICU Patients

Missing Microbes: How the Overuse of Antibiotics Is Fueling Our Modern Plagues

Cytokine Storm Syndrome

Handbook of Drugs in Intensive Care: An A-Z Guide

The Intensivist’s Challenge: Aging and Career Growth in a High-Stress Medical Specialty

Expectations of Recovery: ICU Anecdotes

The Next Pandemic: On the Front Lines Against Humankind’s Gravest Dangers

Abdominal Sepsis: A Multidisciplinary Approach

Hemodynamic Monitoring Using Echocardiography in the Critically Ill

Bedside Procedures in the ICU

Trauma Team Dynamics: A Trauma Crisis Resource Management Manual

Evidence-Based Critical Care: A Case Study Approach

Clinical Examination Skills in the Adult Critically Ill Patient

Severe Trauma and Sepsis: Organ Damage and Tissue Repair

Moderate and Deep Sedation in Clinical Practice

Basics of Mechanical Ventilation